NEW YORK (GenomeWeb) – Private investment fund StoneCalibre today announced the acquisition of DNA sequencing consumables firm Edge Biosystems for an undisclosed amount.

Based in Gaithersburg, Md., EdgeBio manufactures and distributes sample preparation and clean-up products for DNA sequencing. Its products are used in clinical and diagnostic laboratories, food testing, molecular medicine, ancestry studies, and other applications. The company was founded in 1990.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: Icelandic genome sequences, approach to increase CRISPR efficiency, and more.

Testing showing "genetic incompatibilities" have led thousands of couples in Saudi Arabia to call off their weddings, the BBC reports.

Decode Genetics' ability to tell Icelanders, even ones the company hasn't sequenced, about their disease risk brings up ethical questions.

Genetic analysis of Britain's King Richard III and modern descendants of his relatives indicate breaks in the male line.

Apr
15
Sponsored by
WaferGen

This live online seminar will highlight recent trends in applying next-generation sequencing in the clinical setting, with a particular focus on oncology and rare disease.